NEJM Retracts Avacopan Vasculitis Study - Quiz - MDSpire

NEJM Retracts Avacopan Vasculitis Study

"The primary end-point assessments in nine patients were readjudicated after database lock and trial unblinding"

  • By

  • Kathryn Wighton

  • July 1, 2026

  • 3 min

Share

Original Source(s)

NEJM Retracts Avacopan Vasculitis Study

  • by Kathryn Wighton

  • July 1, 2026

Related Content

HHS Announces Department-Wide Clinical Trial Initiative

Agency-wide effort targets US clinical trial timelines, enrollment, and regulatory barriers.

Hair Repigmentation Reported With Baricitinib in Canities Subita

A single case suggests a possible benefit, but confounding factors and the off-label setting temper the conclusions.

Lactate Biomarker May Predict Outcomes in Cardiogenic Shock

A review of cardiogenic shock studies suggests serial lactate measurements provide more prognostic information than isolated values and may better reflect treatment response.